Literature DB >> 4263632

Demethylation of L-3-methoxytyrosine in vivo.

G Bartholini, A Pletscher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4263632     DOI: 10.1007/bf00501277

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  10 in total

1.  Dynamic aspects of enzymatic O-methylation and -demethylation of catechols in vitro and in vivo.

Authors:  J W DALY; J AXELROD; B WITKOP
Journal:  J Biol Chem       Date:  1960-04       Impact factor: 5.157

2.  The enzymic cleavage of aromatic ethers.

Authors:  J AXELROD
Journal:  Biochem J       Date:  1956-08       Impact factor: 3.857

3.  Formation of dopamine from 3-methoxytyrosine. Fact or artifact?

Authors:  A Carlsson; B Waldeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  3-O-methyldopa, a new precursor of dopamine.

Authors:  G Bartholini; I Kuruma; A Pletscher
Journal:  Nature       Date:  1971-04-23       Impact factor: 49.962

5.  The metabolic pathways of L-3-O-methyldopa.

Authors:  G Bartholini; I Kuruma; A Pletscher
Journal:  J Pharmacol Exp Ther       Date:  1972-10       Impact factor: 4.030

6.  [Therapy of parkinsonian syndromes and plasmatic DOPA levels. Effects of L-DOPA and 3-OMD, administered alone or combined, with or without a decarboxylase inhibitor].

Authors:  F Geissbühler; J M Gaillard; J J Eisenring; M Krassoievitch; G Yanniotis; R Tissot
Journal:  Rev Eur Etud Clin Biol       Date:  1972-01

7.  [Substitution therapy of parkinsonism. Insufficient results with 3-0-methyldopa].

Authors:  J Ajuriaguerra; G Gauthier; F Geissbuhler; B Simona; J Constantinidis; G Yanniotis; M Krassoievitch; J Eisenring; R Tissot
Journal:  Presse Med       Date:  1971-06-19       Impact factor: 1.228

8.  L-dopa-induced accumulation of 3-O-metyldopa in brain and heart.

Authors:  I Kuruma; G Bartholini; A Pletscher
Journal:  Eur J Pharmacol       Date:  1970-05       Impact factor: 4.432

9.  [Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa?].

Authors:  G Gauthier; J de Ajuriaguerra; F Geissbuhler; B Simona; J Constantinidis; G Yanniotis; M Krassoievitch; J J Eisenring; R Tissot
Journal:  Presse Med       Date:  1971-01-16       Impact factor: 1.228

10.  The metabolism of L-3-O-methyldopa, a precursor of dopa in man.

Authors:  I Kuruma; G Bartholini; R Tissot; A Pletscher
Journal:  Clin Pharmacol Ther       Date:  1971 Jul-Aug       Impact factor: 6.875

  10 in total
  2 in total

1.  Influence of L-3-methoxytyrosine on monoamine synthesis in rat brain.

Authors:  W Kehr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Methoxytyrosine formation as an indicator of catechol-O-methyltransferase activity in rat liver in vivo.

Authors:  W Kehr; R Zimmermann; M Thiede
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.